azacitidine has been researched along with Blood Poisoning in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ades, L; Banos, A; Beve, B; Chait, Y; Chaury, MP; Cheze, S; Cluzeau, T; Dartigeas, C; Delaunay, J; Dombret, H; Dreyfus, F; Fenaux, P; Gardin, C; Guerci, A; Ifrah, N; Isnard, F; Itzykson, R; Marfaing Koka, A; Marolleau, JP; Morel, P; Pautas, C; Plantier, I; Quesnel, B; Raffoux, E; Recher, C; Seegers, V; Stamatoullas, A; Taksin, AL; Thépot, S; Thomas, X; Vey, N | 1 |
Barani, B; Dawn, B; Rajasingh, J; Rajasingh, S; Samanta, S; Thangavel, J; Xuan, YT | 1 |
Kalayoğlu Beşışık, S; Turan Erkek, E | 1 |
Jones, PA; Pillai, AR; Sadik, W; Thachil, J | 1 |
Cashen, AF; DiPersio, J; Fisher, N; Shah, AK; Todt, L | 1 |
1 trial(s) available for azacitidine and Blood Poisoning
Article | Year |
---|---|
Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Area Under Curve; Azacitidine; Bone Marrow; Chromatography, High Pressure Liquid; Decitabine; Drug Administration Schedule; Female; Half-Life; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Mass Spectrometry; Middle Aged; Myelodysplastic Syndromes; Sepsis; Tissue Distribution | 2008 |
4 other study(ies) available for azacitidine and Blood Poisoning
Article | Year |
---|---|
Azacitidine in untreated acute myeloid leukemia: a report on 149 patients.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Cohort Studies; Compassionate Use Trials; Febrile Neutropenia; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Sepsis; Treatment Outcome | 2014 |
Epigenetic modifiers reduce inflammation and modulate macrophage phenotype during endotoxemia-induced acute lung injury.
Topics: Acute Lung Injury; Animals; Azacitidine; Decitabine; Drug Combinations; Endotoxemia; Epigenesis, Genetic; Histone Deacetylases; Humans; Hydroxamic Acids; Inflammation; Lipopolysaccharides; Macrophages; Methyltransferases; Mice; Sepsis; Signal Transduction | 2015 |
An Unexpected Innocent Complication Associated with Azacitidine Treatment of Myelodysplastic Syndrome: Erythema Annulare Centrifugum.
Topics: Aged; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Breast Neoplasms; Chemoradiotherapy; Drug Hypersensitivity; Erythema; Fatal Outcome; Female; Humans; Mastectomy, Radical; Sepsis | 2016 |
Interstitial pneumonitis--An important differential diagnosis for pulmonary sepsis in haematology patients.
Topics: Aged; Antineoplastic Agents; Azacitidine; Diagnosis, Differential; Female; Hematology; Humans; Lung Diseases, Interstitial; Myelodysplastic Syndromes; Pneumonia; Sepsis | 2012 |